Insider Transactions Reported by 22 Insiders of vTv Therapeutics Inc.

Symbol
VTVT on Nasdaq
Location
High Point, NC

There are no Buy or Sell transactions made by insiders since 18 Mar 2025

vTv Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Srinivas Akkaraju Director $76,395,257 22 Sep 2025
Ronald O Perelman 10%+ Owner $30,482,586 20 Dec 2021
Deepa Prasad President and CEO, Director $29,508,879 19 Oct 2021
Paul J. Sekhri Pres, CEO and Exec Chairperson, Director $19,438,955 17 Feb 2026
Samsara BioCapital GP, LLC 10%+ Owner $14,038,836 05 Mar 2024
Rich S. Nelson Acting Chief Executive Officer, Director $5,905,000 03 Mar 2022
Michael Stephen Tung Evp & Cfo $3,321,655 17 Feb 2026
Keith R. Harris Director $1,203,000 19 Jun 2023
John A. Fry Director $1,203,000 19 Jun 2023
Chandresh Harjivan Director $1,203,000 19 Jun 2023
Hersh Kozlov Director $1,203,000 19 Jun 2023
Howard L. Weiner Director $1,203,000 19 Jun 2023
Steven L. Tuch Chief Financial Officer $881,723 27 Feb 2024
Fahed Al-Marzooqi Director $224,877 10 Jun 2025
Anne M. Phillips Director $180,167 10 Jun 2025
Daniel K. Spiegelman Director $165,900 10 Jun 2025
Barry K. Brown Chief Accounting Officer $68 11 Apr 2025
Dr. Raymond Cheong Director 27 Feb 2024
G42 Investments AI Holdings RSC Ltd. Director, 10%+ Owner 31 May 2022
BAKER BROS. ADVISORS LP Director 03 Sep 2025
Hh Sheikh Tahnoon bin Zayed S. Al-Nahyan 10%+ Owner 31 May 2022
Jonathan Isaacsohn Director 17 Aug 2022

Recent Insider Transactions by Companies or Individuals for vTv Therapeutics Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Michael Stephen Tung VTVT Employee stock option (right to buy) Award 99.9% 44,969 89,969 17 Feb 2026 Direct
Paul J. Sekhri VTVT Class A Common Stock Award 55.5% 140,000 392,212 17 Feb 2026 Direct
Srinivas Akkaraju VTVT Class A Common Stock Award 106,000 106,000 22 Sep 2025 By Samsara Opportunity Fund, L.P.
Srinivas Akkaraju VTVT Warrant (Right to Buy) Award 983,214 983,214 22 Sep 2025 By Samsara Opportunity Fund, L.P.
Srinivas Akkaraju VTVT Pre-Funded Warrants (Right to Buy) Award 877,214 877,214 22 Sep 2025 By Samsara Opportunity Fund, L.P.
Srinivas Akkaraju VTVT Warrant to Purchase Class A Common Stock (Right to Buy) Award 655,523 655,523 03 Sep 2025 By Samsara BioCapital, L.P.
Srinivas Akkaraju VTVT Pre-Funded Warrants (Right to Buy) Award 73.4% 655,523 1,548,101 03 Sep 2025 Samsara BioCapital, L.P.
Baker Bros. Advisors Lp VTVT Common Stock Award 60% 51,000 135,946 03 Sep 2025 See Footnotes
Baker Bros. Advisors Lp VTVT Common Warrant Award 2,622,057 2,400,605 03 Sep 2025 See Footnotes
Baker Bros. Advisors Lp VTVT Prefunded Warrants Award 98.7% 2,571,057 5,176,974 03 Sep 2025 See Footnotes
Baker Bros. Advisors Lp VTVT Non- Qualified Stock Option (right to buy) Award 8,000 4,000 10 Jun 2025 See Footnotes
Daniel K. Spiegelman VTVT Director stock option (right to buy) Award 66.7% 4,000 10,000 10 Jun 2025 Direct
Srinivas Akkaraju VTVT Director stock option (right to buy) Award 57.3% 4,000 10,983 10 Jun 2025 Direct
Anne M. Phillips VTVT Director stock option (right to buy) Award 58.3% 4,000 10,860 10 Jun 2025 Direct
Fahed Al-Marzooqi VTVT Director stock option (right to buy) Award 41.9% 4,000 13,555 10 Jun 2025 Direct
Michael Stephen Tung VTVT Employee stock option (right to buy) Award 45,000 45,000 19 May 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.